Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6821105 | 0.97 | THRB (0.59) | — | |
| SCHEMBL19409375 | 0.97 | THRB (0.64) | — | |
| SCHEMBL15030 | 0.97 | — | — | |
| Methylamine SCHEMBL28938689 | 0.95 | THRB (0.57) | — | |
| Hydrochloric Acid SCHEMBL28857069 | 0.95 | THRB (0.57) | — | |
| Ammonia Solution, Strong SCHEMBL2598325 | 0.95 | — | — | |
| Charcoal, Activated SCHEMBL7592908 | 0.95 | — | — | |
| Acetone SCHEMBL11325819 | 0.95 | THRB (0.61) | — | |
| Ethane SCHEMBL21616541 | 0.95 | THRB (0.61) | — | |
| SCHEMBL11457945 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021383-B1 | BIOADHESIVE PARTICLES COMPRISING ACTIVE AGENTS, AND USES THEREOF | SKINOSIVE (FR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4518841-B1 | DOSAGE FORM WITH DRUG RELEASE AT PH 3 TO 6 USING DOUBLE COATING SYSTEM WITH AT LEAST ONE RELEASE ACCELERATION AGENT | EVONIK OPERATIONS GMBH (DE) | 2025-12-17 | — | — | EP | disclosed |
| US-20250295597-A1 | DOSAGE FORM WITH DRUG RELEASE AT PH 3 TO 6 USING DOUBLE COATING SYSTEM WITH AT LEAST ONE RELEASE ACCELERATION AGENT | EVONIK OPERATIONS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20250177315-A1 | PRE-FUNCTIONALIZED HARD SHELL CAPSULE WITH ACCELERATED DRUG RELEASE AT PH VALUE 5 TO 5.5 | EVONIK OPERATIONS GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| US-20250177332-A1 | PHARMACEUTICAL DOSAGE FORM OF LACOSAMIDE | SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) | 2025-06-05 | — | — | US | disclosed |
| US-20250107974-A1 | MICROCAPSULES COMPRISING SUNSCREEN AGENTS | TAGRA BIOTECHNOLOGIES LTD. (IL) | 2025-04-03 | — | — | US | disclosed |
| EP-4518841-A1 | DOSAGE FORM WITH DRUG RELEASE AT PH 3 TO 6 USING DOUBLE COATING SYSTEM WITH AT LEAST ONE RELEASE ACCELERATION AGENT | Evonik Operations GmbH (DE) | 2025-03-12 | — | — | EP | disclosed |
| US-20250025433-A1 | LACOSAMIDE PHARMACEUTICAL COMPOSITION AND DOSAGE FORM THEREOF | SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) | 2025-01-23 | — | — | US | disclosed |
| EP-4493165-A1 | PRE-FUNCTIONALIZED HARD SHELL CAPSULE WITH ACCELERATED DRUG RELEASE AT PH VALUE 5 TO 5.5 | Evonik Operations GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| US-12201708-B2 | Microcapsules comprising sunscreen agents | TAGRA BIOTECHNOLOGIES LTD. (IL) | 2025-01-21 | — | — | US | disclosed |
| EP-1680222-A1 | MOLECULAR SIEVE CATALYST COMPOSITION, ITS MAKING AND USE IN CONVERSION PROCESSES | ExxonMobil Chemical Patents, Inc. a Corporation of the State of Delaware (US) | 2006-07-19 | — | — | EP | disclosed |
| US-20060039997-A1 | Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration | VAL PHARMA S.A. (SM) | 2006-02-23 | — | — | US | disclosed |
| WO-2005113145-A1 | MOLECULAR SIEVE CATALYST COMPOSITION, ITS MAKING AND USE IN CONVERSION PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050256354-A1 | Molecular sieve catalyst composition, its making and use in conversion processes | SUD CHEMIC AG (DE) | 2005-11-17 | — | — | US | disclosed |
| WO-2005035120-A1 | MOLECULAR SIEVE CATALYST COMPOSITION, ITS MAKING AND USE IN CONVERSION PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-04-21 | — | — | WO | disclosed |
| US-20050065021-A1 | Molecular sieve catalyst composition, its making and use in conversion processes | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-03-24 | — | — | US | disclosed |
| US-20040168598-A1 | Printing plate material, process of folding the same, and printing process | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-09-02 | — | — | US | disclosed |
| US-5609987-A | OLEOPHILIC TANNING SYNTHETIC RESIN | DU PONT (U.K.) LIMITED (GB) | 1997-03-11 | — | — | US | disclosed |
| US-4695532-A | Photographic silver halide element containing new adhesion promoting polymeric materials and polyester support | EASTMAN KODAK COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| US-4689359-A | SUBBING LAYERS FOR PHOTOGRAPHIC FILM SUPPORTS; ADHESION | EASTMAN KODAK COMPANY (US) | 1987-08-25 | — | — | US | disclosed |